Portfolio

Top 10 Holdings as of 3/31/2019

Celgene Corporation 7.8%
Amgen Inc. 7.0%
Gilead Sciences, Inc. 6.0%
Vertex Pharmaceuticals Incorporated 4.4%
Biogen Inc. 4.20%
Illumina, Inc. 4.10%
Regeneron Pharmaceuticals, Inc. 3.5%
Alexion Pharmaceuticals, Inc. 3.0%
Incyte Corporation 2.5%
Merck & Co., Inc. 1.7%

This data is subject to change on a daily basis. Percentage is based on net assets.

Sub-Sector Allocation as of 3/31/2019

Biotechnology 64.2%
Pharmaceuticals 15.7%
Life Sciences Tools & Services 5.8%
Healthcare Equipment & Supplies 4.0%
Repurchase Agreement 4.0%
Health Care Providers & Services 3.1%
Medical Devices and Diagnostics 1.6%
Exchange Traded Fund 0.7%
Healthcare Services 0.2%
Health Care Technology 0.1%
Other liabilities in excess of assets 0.6%

This data is subject to change on a daily basis. Percentage is based on net assets.

Asset Allocation as of 3/31/2019

Equity 89.8%
Short-Term Investment 4.0%
Convertible Preferred and Warrants 3.3%
Milestone Interests 1.4%
Exchange Traded Fund 0.7%
Notes 0.2%
Other Liabilities In Excess Of Assets 0.6%

This data is subject to change on a daily basis. Percentage is based on net assets.